XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 27.13

+1.7%

Jan 13 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (10348)	6/9/1999 1:52:00 AM
From: aknahow	Read Replies (3) of 17367

Your failure to find this may cause you to eat your heart out. This article goes straight to the heart of the matter. Available free with registration. Current May 29 issue. thelancet.com Endotoxin and immune activation in chronic heart failure: a prospective cohort study <<<<<<< These results lend credance to the hypothesis that bacterial endotoxin may be an important stimulus of immune activation in patients with chronic heart failure. This finding may open various options for treatment of patients with chronic heart failure that could be directed against bacteria in the bowel, the translocation process, and endotoxin itself, the binding sites of bacterial endotoxin on immune competent cells, or both.>>>>>>>>>>> Above is very minimal quote from entire article.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next